Brain diseases, especially neurodegenerative disorders, affect millions of people worldwide, and present a heavy burden to modern society.
Diseases such as Parkinson’s, Alzheimer’s, Huntington’s and strokes all present different symptoms and issues for the patient, yet they share common underlying factors in that they all result from nerve cells in the brain or peripheral nervous system losing function and/or dying. For many neurodegenerative disorders, there are no known cures.
Half of the ten UK areas with the highest proportion of over 65's are in the South West, making Plymouth a unique location for research on neurodegenerative diseases in the UK.
At the University’s Institute of Translational and Stratified Medicine (ITSMed), there is high-quality research across clinical neuroscience that seeks to broaden understanding of these life-changing diseases.
The event will showcase some of the latest research in this field, highlighting the importance of patient-driven research and the potential for widespread impact in these areas, but also how these synergies can positively impact on other wider, related research.
The event will also explore how important public engagement is to scientific progress, encouraging greater interaction between researchers and the public, and highlighting the opportunities for charitable support of local research.
09:00 | Arrival and welcome
09:15 | Keynote: Mark Poarch, CEO of BRACE, and Professor Stephen Lisney, BRACE Chair of Trustees
09:45 | Research showcase
- Alexander disease
- Huntington’s and neurodegeneration
- Parkinson’s and dementia with lewy bodies
10:45 | Demonstrations
11:30 | Ask a scientist: panel Q&A
Your opportunity to find out more about the work that has been shared in the showcase, and hear experiences from patients involved in the research.
Who is this event for?
This event will be of most appropriate for anyone interested in research of the brain, particularly prospective students, patients and caregivers, fellow researchers, and those who may be curious about the opportunities to support ongoing research.